Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Role of defibrillation threshold testing in the contemporary defibrillator patient population.

Vischer AS, Sticherling C, Kühne MS, Osswald S, Schaer BA.

J Cardiovasc Electrophysiol. 2013 Apr;24(4):437-41. doi: 10.1111/jce.12042. Epub 2012 Dec 4.

PMID:
23210803
[PubMed - indexed for MEDLINE]
2.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

PMID:
17470697
[PubMed - indexed for MEDLINE]
Free Article
3.

Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.

Sadoul N, Defaye P, Mouton E, Bizeau O, Dupuis JM, Blangy H, Delarche N, Blanc JJ, Lazarus A; LEADER registry investigators.

Arch Cardiovasc Dis. 2013 Nov;106(11):562-9. doi: 10.1016/j.acvd.2013.07.002. Epub 2013 Nov 4.

PMID:
24200925
[PubMed - indexed for MEDLINE]
4.

Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.

Leong-Sit P, Gula LJ, Diamantouros P, Krahn AD, Skanes AC, Yee R, Klein GJ.

Am Heart J. 2006 Dec;152(6):1104-8.

PMID:
17161062
[PubMed - indexed for MEDLINE]
5.

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators.

J Am Coll Cardiol. 2008 Aug 12;52(7):551-6. doi: 10.1016/j.jacc.2008.04.051.

PMID:
18687249
[PubMed - indexed for MEDLINE]
Free Article
6.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

PMID:
23180517
[PubMed - indexed for MEDLINE]
Free Article
7.

Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?

Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE.

Heart Rhythm. 2005 May;2(5):456-61.

PMID:
15840466
[PubMed - indexed for MEDLINE]
8.

Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Aktas MK, Huang DT, Daubert JP, Schuger CD, McNitt S, Goldenberg I, Moss AJ, Zareba W.

Heart Rhythm. 2013 Feb;10(2):193-9. doi: 10.1016/j.hrthm.2012.10.024. Epub 2012 Oct 18.

PMID:
23085128
[PubMed - indexed for MEDLINE]
9.

Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.

Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.

Clin Cardiol. 2011 Oct;34(10):604-9. doi: 10.1002/clc.20949. Epub 2011 Sep 1.

PMID:
21887690
[PubMed - indexed for MEDLINE]
10.

Dyssynchrony and the risk of ventricular arrhythmias.

Kutyifa V, Pouleur AC, Knappe D, Al-Ahmad A, Gibinski M, Wang PJ, McNitt S, Merkely B, Goldenberg I, Solomon SD, Moss AJ, Zareba W.

JACC Cardiovasc Imaging. 2013 Apr;6(4):432-44. doi: 10.1016/j.jcmg.2012.12.008.

PMID:
23579010
[PubMed - indexed for MEDLINE]
Free Article
11.

Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.

Green UB, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK.

J Interv Card Electrophysiol. 2003 Feb;8(1):71-5.

PMID:
12652181
[PubMed - indexed for MEDLINE]
12.

Shock or no shock - a question of philosophy or should intraoperative implantable cardioverter defibrillator testing be recommended?

Keyser A, Hilker MK, Schmidt S, von Bary C, Zink W, Ried M, Schmid C, Diez C.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):321-5. doi: 10.1093/icvts/ivs479. Epub 2012 Dec 7.

PMID:
23223668
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.

Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.

PMID:
21955243
[PubMed - indexed for MEDLINE]
14.

Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(12):1264-75.

PMID:
23264245
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.

Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Swiatecka G.

Kardiol Pol. 2005 Apr;62(4):317-28; discussion 329-31. English, Polish.

PMID:
15928737
[PubMed - indexed for MEDLINE]
16.

Automated vulnerability testing identifies patients with inadequate defibrillation safety margin.

Birgersdotter-Green U, Ruetz LL, Anand K, Monir G, Abeyratne AI, Bailey JR, Shorofsky SR, Hsia HH, Friedman PA.

Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1073-80. doi: 10.1161/CIRCEP.112.971275. Epub 2012 Oct 10.

PMID:
23051838
[PubMed - indexed for MEDLINE]
Free Article
17.

Predictors of successful defibrillation threshold test during CRT-D implantation.

Przybylski A, Oreziak A, Lewandowski Z, Hasiec A, Orczykowski M, Walczak F.

Kardiol Pol. 2010 May;68(5):512-8.

PMID:
20491010
[PubMed - indexed for MEDLINE]
Free Article
18.

Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.

Boriani G, Braunschweig F, Deharo JC, Leyva F, Lubinski A, Lazzaro C.

Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.

PMID:
23696624
[PubMed - indexed for MEDLINE]
19.

Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?

Curtis AB.

J Am Coll Cardiol. 2008 Aug 12;52(7):557-8. doi: 10.1016/j.jacc.2008.05.016. No abstract available.

PMID:
18687250
[PubMed - indexed for MEDLINE]
Free Article
20.

T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy.

Lezcano AO, Aracama JM, Ayestaran VU, Urra FG.

Cardiol J. 2009;16(6):580-1.

PMID:
19950098
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk